RxDoctor Payments DataLook up a doctor →

Brittany McClain

Family · Canton, OHNPI 1245796507

Payments from drug & device makers

$16,641in general payments, 2019–2025

Across 981 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SK Life Science, Inc.$1K
  • UCB, Inc.$1K
  • AbbVie$1K
  • Amgen$801
  • Jazz Pharmaceuticals Inc.$741
  • Neurocrine Biosciences, Inc.$698
  • plus $11K from 54 others

What the payments were for

  • Food & beverage$16,48599%
  • Education$1551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SK Life Science, Inc.77$1,337
UCB, Inc.51$1,302
AbbVie65$1,154
Amgen(2 entities)54$801
Jazz Pharmaceuticals Inc.40$741
Neurocrine Biosciences, Inc.38$698
EMD Serono, Inc.42$634
Teva Pharmaceuticals USA, Inc.46$588
AstraZeneca30$556
Lilly USA, LLC26$542
Genentech USA, Inc.40$538
Pfizer51$535
Lundbeck LLC25$532
Harmony Biosciences LLC32$489
Biogen41$416
Acadia Pharmaceuticals Inc19$404
Novartis37$382
Biohaven Pharmaceutical Holding Company Ltd.16$321
Sumitomo Pharma America, Inc.29$315
Argenx US, Inc.11$266
Sanofi13$266
Neurelis, Inc.15$249
Corium, LLC9$234
Eisai Inc.14$226
Bristol Myers Squibb15$208
Avadel CNS Pharmaceuticals, LLC9$199
Xeris Pharmaceuticals, Inc.11$187
Amneal Pharmaceuticals LLC9$179
Takeda Pharmaceuticals U.S.A., Inc.7$167
Kyowa Kirin, Inc.10$158
Axsome Therapeutics, Inc.8$158
Vanda Pharmaceuticals Inc.6$149
Acorda Therapeutics, Inc8$125
Livanova USA, Inc.1$117
Sunovion Pharmaceuticals Inc.7$113
TG Therapeutics, Inc.5$108
E.r. Squibb & Sons, L.L.C.1$101
Avion Pharmaceuticals6$90
Biohaven Pharmaceuticals, Inc.5$86
GE HealthCare6$74
Supernus Pharmaceuticals, Inc.3$74
Otsuka America Pharmaceutical, Inc.4$71
Impel Pharmaceuticals LLC4$70
Upsher-smith Laboratories LLC2$66
Johnson & Johnson(2 entities)3$62
Catalyst Pharmaceuticals, Inc.3$61
Scilex Pharmaceuticals Inc.3$46
Alnylam Pharmaceuticals Inc.2$42
Aurinia Pharma U.S., Inc.1$39
Avanir Pharmaceuticals, Inc.2$33
Tanabe Pharma America, Inc.2$28
Collegium Pharmaceutical, Inc.2$28
GRT US Holding, Inc.1$27
Mallinckrodt Hospital Products Inc.1$27
Neos Therapeutics, LP2$26
Impel Pharmaceuticals Inc.1$25
Merck1$22
Amylyx Pharmaceuticals, Inc.1$22
Mylan Specialty L.p.1$20
Grifols USA, LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,641 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$3,879
Medicare patients
21
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate83$93,836
QuliptaAtogepant62$89,281
BriviactBrivaracetam22$49,665
Aimovig AutoinjectorErenumab-Aooe61$46,529
UbrelvyUbrogepant44$45,868
Emgality PenGalcanezumab-Gnlm62$44,052
Ajovy AutoinjectorFremanezumab-Vfrm23$30,291
KeppraLevetiracetam12$27,648
XcopriCenobamate24$25,635
AptiomEslicarbazepine Acetate16$20,377
Emgality SyringeGalcanezumab-Gnlm14$14,981
NuedextaDextromethorphan Hbr/Quinidine11$14,611
Levetiracetam345$11,954
SunosiSolriamfetol Hcl11$9,408
Dalfampridine ErDalfampridine12$6,617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta, Ubrelvy$1,154$135,148106 claims
PfizerNurtec Odt$535$93,83683 claims
UCB, Inc.Briviact$1,302$49,66522 claims
SK Life Science, Inc.Xcopri$1,337$25,63524 claims
Sunovion Pharmaceuticals Inc.Aptiom$113$20,37716 claims
Avanir Pharmaceuticals, Inc.Nuedexta$33$14,61111 claims
Axsome Therapeutics, Inc.Sunosi$158$9,40811 claims
Upsher-smith Laboratories LLCTopiramate$66$2,128279 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →